病院における医薬品の安全性情報の入手・伝達・活用に関する調査

DOI
  • 益山 麻貴
    独立行政法人医薬品医療機器総合機構安全第一部 山形大学大学院医学系研究科
  • 長谷川 浩一
    独立行政法人医薬品医療機器総合機構安全第一部
  • 池田 三恵
    独立行政法人医薬品医療機器総合機構安全第一部
  • 森 和彦
    独立行政法人医薬品医療機器総合機構安全第一部
  • 吉野 景子
    独立行政法人国立病院機構東京医療センター薬剤科
  • 荒 義昭
    独立行政法人国立病院機構東京医療センター薬剤科
  • 宮下 久徳
    独立行政法人国立病院機構東京医療センター薬剤科
  • 井出 康男
    独立行政法人国立病院機構東京医療センター薬剤科
  • 鈴木 義彦
    独立行政法人国立病院機構東京医療センター薬剤科
  • 林 昌洋
    国家公務員共済組合連合会虎ノ門病院薬剤部
  • 松田 勉
    山形大学大学院医学系研究科

書誌事項

タイトル別名
  • A Survey of the Collection, Provision, and Application of Drug Safety Information at Hospitals

この論文をさがす

説明

Objective: We conducted a questionnaire survey to comprehend the situation regarding the collection, provision, and utilization of drug safety information at hospitals.  In addition, we asked pharmaceutical companies how they select medical institutions to provide drug safety information.  We also investigated the current situation of information provision to Tokyo Medial Center by pharmaceutical companies.<br>Method: A questionnaire was mailed to all hospitals in Japan.  The survey was conducted between January 13 and February 10, 2011.  Moreover, we asked thirteen pharmaceutical companies by telephone and e-mail about the implementation status of the provision of information and performed a survey at Tokyo Medical Center on the current situation of information provision by pharmaceutical companies regarding revisions to precaution sections in package inserts.<br>Results: The results of the questionnaire survey (response rate: 41.2%) showed that the major information sources for hospitals were medical representatives (77.8%), Drug Safety Update (50.3%) and direct mails (49.3%).  Furthermore, in the case of drugs prescribed exclusively for extramural dispensing, fewer hospitals responded that medical representatives of the pharmaceutical companies provided drug safety information and more hospitals responded that they did not obtain any drug safety information at all, compared with drugs listed in the hospital formularies.<br>Conclusion: To minimize the risks of drugs, healthcare professionals must collect a wide range of drug safety information and must utilize this information in their medical practice.  Therefore, it is important that pharmaceutical companies and regulatory authorities make an effort to provide suitable information dissemination to medical institutions.  Furthermore, medical institutions must also strengthen their systems for collecting drug safety information and providing such information to healthcare professionals.

収録刊行物

  • 医薬品情報学

    医薬品情報学 14 (4), 170-178, 2013

    一般社団法人　日本医薬品情報学会

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ